QuantumSi Inc
$ 0.86
0.83%
19 May - close price
- Market Cap 193,828,000 USD
- Current Price $ 0.86
- High / Low $ 0.87 / 0.82
- Stock P/E N/A
- Book Value 1.02
- EPS -0.50
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.25 %
- ROE -0.46 %
- 52 Week High 3.10
- 52 Week Low 0.69
About
Quantum-Si incorporated operates the first next-generation protein sequencing platform for the healthcare industries.
Analyst Target Price
$2.50
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-07 | 2026-03-03 | 2025-11-05 | 2025-08-05 | 2025-05-15 | 2025-03-03 | 2024-11-12 | 2024-08-07 | 2024-05-09 | 2024-02-29 | 2023-11-09 | 2023-08-07 |
| Reported EPS | -0.0892 | -0.0762 | -0.17 | -0.16 | -0.1088 | -0.1636 | -0.1778 | -0.16 | -0.14 | -0.16 | -0.17 | -0.18 |
| Estimated EPS | -0.1174 | -0.1233 | -0.13 | -0.14 | -0.14 | -0.19 | -0.19 | -0.19 | -0.2 | -0.18 | -0.19 | -0.2 |
| Surprise | 0.0282 | 0.0471 | -0.04 | -0.02 | 0.0312 | 0.0264 | 0.0122 | 0.03 | 0.06 | 0.02 | 0.02 | 0.02 |
| Surprise Percentage | 24.0204% | 38.1995% | -30.7692% | -14.2857% | 22.2857% | 13.8947% | 6.4211% | 15.7895% | 30% | 11.1111% | 10.5263% | 10% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: QSI
2026-05-15 20:41:30
Quantum-Si Inc. shareholders reelected all ten director nominees, ratified PricewaterhouseCoopers LLP as their independent auditor, and approved executive compensation during their recent annual meeting. This occurred amidst operational challenges for the company, including a 37% stock price decline over the past year and a 46% revenue decrease, despite exceeding Q1 2026 earnings and revenue expectations.
2026-05-08 18:40:24
Quantum-Si Inc (QSI) reported its Q1 2026 earnings, emphasizing significant progress in its Proteus platform development and its strategy in proteomics research tools. The company’s focus is on next-generation protein sequencing technology, aiming to create a hardware-consumables-software ecosystem for academic, biopharmaceutical, and clinical research. While the stock's valuation reflects expectations for future growth, the company acknowledges typical risks associated with early-stage life sciences technology firms.
2026-05-08 07:39:31
Quantum-Si Incorporated reported its Q1 2026 earnings, showing a significant decrease in total revenue by 69.4% compared to Q1 2025, primarily due to customers delaying purchases in anticipation of the Proteus platform launch. The company continues to invest heavily in research and development, particularly for the upcoming Proteus next-generation protein sequencing platform, anticipated to launch by the end of 2026. Despite a net loss, the company maintains sufficient liquidity with $190.4 million in cash and marketable securities, expecting these to fund operations for at least the next 12 months.
2026-05-08 07:09:47
Quantum-Si (NASDAQ: QSI) reported its Q1 2026 financial results, with revenues of $258,000 and a net loss of $21.7 million, as the company continues to invest heavily in its Proteus single-molecule protein sequencing system. The company reiterated its full-year 2026 guidance, focusing on the anticipated commercial launch of Proteus by the end of 2026. Quantum-Si maintains a strong cash position of $190.4 million, expected to fund operations into Q2 2028.
2026-05-07 18:09:28
Quantum-Si (NASDAQ:QSI) has a cash runway of about 20 months based on its current burn rate of US$97m against US$163m in cash. The company's cash burn increased by 5.2% year-on-year, and operating revenue decreased by 20%, raising concerns about its development. Furthermore, its cash burn represents 47% of its market capitalization, suggesting potential significant shareholder dilution if more capital is needed.
2026-04-22 21:39:08
Quantum-Si CFO Jeffry Keyes sold $74,815 worth of Class A Common Stock over two days in April 2026, representing shares sold to cover withholding taxes from restricted stock unit vesting. Following these mandatory transactions, Mr. Keyes directly holds 1,732,582 shares. The company recently reported mixed Q4 2025 financial results and announced a multi-city roadshow for its Proteus protein sequencing platform.
